Drug Trial Radar · NCT04068051
Multimechanistic Treatment Over Time of Migraine Symptoms (MOVEMENT)
Last checked: Nov 19, 2026Latest source record: Oct 10, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
706
Actual
Start
Jul 6, 2019
Primary completion
Sep 22, 2020
Study completion Sep 22, 2020
Sponsor
- Lead sponsor
- Axsome Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Aug 28, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
MOVEMENT (Multimechanistic Treatment over Time of Migraine Symptoms) is a Phase 3 study to evaluate the long-term safety of chronic intermittent use of AXS-07 and to assess the effect of AXS-07 on migraine symptoms following repeated treatment of migraine attacks.
Conditions
- Migraine
Interventions
AXS-07Drug
AXS-07 (MoSEIC meloxicam and rizatriptan) taken by mouth for the acute treatment of migraine.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Long-term Safety of Chronic Intermittent Use of AXS-07Time frame: Up to 12 months
Locations
51 sites in 1 country. Site status is shown where the registry gives one.
Clinical Research Site
Birmingham, Alabama
Clinical Research Site
Birmingham, Alabama
Clinical Research Site
Mobile, Alabama
Clinical Research Site
Phoenix, Arizona
Clinical Research Site
Canoga Park, California
Clinical Research Site
Colton, California
Clinical Research Site
Encino, California
Clinical Research Site
Los Alamitos, California
Clinical Research Site
Los Angeles, California
Clinical Research Site
Los Angeles, California
Clinical Research Site
San Diego, California
Clinical Research Site
Spring Valley, California
Clinical Research Site
Walnut Creek, California
Clinical Research Site
Hallandale, Florida
Clinical Research Site
Jacksonville, Florida
Clinical Research Site
Lake City, Florida
Clinical Research Site
Lake Worth, Florida
Clinical Research Site
Miami, Florida
Clinical Research Site
Ocoee, Florida
Clinical Research Site
Orlando, Florida
Clinical Research Site
Ormond Beach, Florida
Clinical Research Site
Tampa, Florida
Clinical Research Site
Stockbridge, Georgia
Clinical Research Site
Evanston, Illinois
Clinical Research Site
Louisville, Kentucky
Clinical Research Site
Boston, Massachusetts
Clinical Research Site
North Dartmouth, Massachusetts
Clinical Research Site
Waltham, Massachusetts
Clinical Research Site
Ann Arbor, Michigan
Clinical Research Site
Minneapolis, Minnesota
Clinical Research Site
Springfield, Missouri
Clinical Research Site
Las Vegas, Nevada
Clinical Research Site
Albuquerque, New Mexico
Clinical Research Site
Manlius, New York
Clinical Research Site
Rochester, New York
Clinical Research Site
Williamsville, New York
Clinical Research Site
High Point, North Carolina
Clinical Research Site
Cincinnati, Ohio
Clinical Research Site
Columbus, Ohio
Clinical Research Site
Oklahoma City, Oklahoma
Showing 40 of 51 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.